Application of POCUS in patients with COVID-19 for acute respiratory distress syndrome management: a narrative review.
BMC Pulm Med
; 22(1): 52, 2022 Feb 05.
Article
in En
| MEDLINE
| ID: mdl-35123448
ABSTRACT
COVID-19 has inflicted the world for over two years. The recent mutant virus strains pose greater challenges to disease prevention and treatment. COVID-19 can cause acute respiratory distress syndrome (ARDS) and extrapulmonary injury. Dynamic monitoring of each patient's condition is necessary to timely tailor treatments, improve prognosis and reduce mortality. Point-of-care ultrasound (POCUS) is broadly used in patients with ARDS. POCUS is recommended to be performed regularly in COVID-19 patients for respiratory failure management. In this review, we summarized the ultrasound characteristics of COVID-19 patients, mainly focusing on lung ultrasound and echocardiography. Furthermore, we also provided the experience of using POCUS to manage COVID-19-related ARDS.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Respiratory Therapy
/
Echocardiography
/
Point-of-Care Testing
/
COVID-19
/
Lung
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
BMC Pulm Med
Year:
2022
Document type:
Article